Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

E Spratt

Showing results (431-440 of 666) with videos related to

Pageof 67
Sort By:
European Urology Oncology|May 21, 2021
Integrating Prostate-specific Antigen Kinetics into Contemporary Predictive Nomograms of Salvage Radiotherapy After Radical ProstatectomyShauna R Campbell, Martin C Tom, Shree Agrawal, et al.
Cancer Cytopathology|October 20, 2022
Metastatic prostate cancer diagnosed by fine-needle aspiration: Contemporary cytopathologic and biomarker assessment with clinical correlatesRichard L Cantley, Xiaoming Wang, Zachery R Reichert, et al.
The Journal of Urology|October 19, 2013
A prospective pilot study of (89)Zr-J591/prostate specific membrane antigen positron emission tomography in men with localized prostate cancer undergoing radical prostatectomyJoseph R Osborne, David A Green, Daniel E Spratt, et al.
European Urology|May 23, 2024
Risk Stratification of Patients with Recurrence After Primary Treatment for Prostate Cancer: A Systematic ReviewAdam B Weiner, Preeti Kakani, Andrew J Armstrong, et al.
International Journal of Radiation Oncology, Biology, Physics|July 15, 2022
Local Treatment of the Primary Tumor for Patients With Metastatic Cancer (PRIME-TX): A Meta-AnalysisJeffrey M Ryckman, Toms V Thomas, Ming Wang, et al.
European Urology Oncology|July 7, 2024
Use of Decipher Prostate Biopsy Test in Patients with Favorable-risk Disease Undergoing Conservative Management or Radical Prostatectomy in the Surveillance, Epidemiology, and End Results RegistryAlec Zhu, James A Proudfoot, Elai Davicioni, et al.
The Journal of Clinical Endocrinology and Metabolism|June 21, 2019
Adjuvant Radiation Improves Recurrence-Free Survival and Overall Survival in Adrenocortical CarcinomaLaila A Gharzai, Michael D Green, Kent A Griffith, et al.
Journal of Clinical Medicine|July 1, 2020
Tumor Immune Microenvironment Clusters in Localized Prostate Adenocarcinoma: Prognostic Impact of Macrophage Enriched/Plasma Cell Non-Enriched SubtypesNeil K Jairath, Mark W Farha, Sudharsan Srinivasan, et al.
European Urology|December 18, 2018
Androgen Deprivation Therapy and Overall Survival for Gleason 8 Versus Gleason 9-10 Prostate CancerDavid D Yang, Brandon A Mahal, Vinayak Muralidhar, et al.
The Spine Journal : Official Journal of the North American Spine Society|September 2, 2015
Early magnetic resonance imaging biomarkers to predict local control after high dose stereotactic body radiotherapy for patients with sarcoma spine metastasesDaniel E Spratt, Julio Arevalo-Perez, Jonathan E Leeman, et al.
Pageof 67

Showing results (431-440 of 666) with videos related to

Sort By:
Pageof 67
European Urology Oncology|May 21, 2021
Integrating Prostate-specific Antigen Kinetics into Contemporary Predictive Nomograms of Salvage Radiotherapy After Radical ProstatectomyShauna R Campbell, Martin C Tom, Shree Agrawal, et al.
Cancer Cytopathology|October 20, 2022
Metastatic prostate cancer diagnosed by fine-needle aspiration: Contemporary cytopathologic and biomarker assessment with clinical correlatesRichard L Cantley, Xiaoming Wang, Zachery R Reichert, et al.
The Journal of Urology|October 19, 2013
A prospective pilot study of (89)Zr-J591/prostate specific membrane antigen positron emission tomography in men with localized prostate cancer undergoing radical prostatectomyJoseph R Osborne, David A Green, Daniel E Spratt, et al.
European Urology|May 23, 2024
Risk Stratification of Patients with Recurrence After Primary Treatment for Prostate Cancer: A Systematic ReviewAdam B Weiner, Preeti Kakani, Andrew J Armstrong, et al.
International Journal of Radiation Oncology, Biology, Physics|July 15, 2022
Local Treatment of the Primary Tumor for Patients With Metastatic Cancer (PRIME-TX): A Meta-AnalysisJeffrey M Ryckman, Toms V Thomas, Ming Wang, et al.
European Urology Oncology|July 7, 2024
Use of Decipher Prostate Biopsy Test in Patients with Favorable-risk Disease Undergoing Conservative Management or Radical Prostatectomy in the Surveillance, Epidemiology, and End Results RegistryAlec Zhu, James A Proudfoot, Elai Davicioni, et al.
The Journal of Clinical Endocrinology and Metabolism|June 21, 2019
Adjuvant Radiation Improves Recurrence-Free Survival and Overall Survival in Adrenocortical CarcinomaLaila A Gharzai, Michael D Green, Kent A Griffith, et al.
Journal of Clinical Medicine|July 1, 2020
Tumor Immune Microenvironment Clusters in Localized Prostate Adenocarcinoma: Prognostic Impact of Macrophage Enriched/Plasma Cell Non-Enriched SubtypesNeil K Jairath, Mark W Farha, Sudharsan Srinivasan, et al.
European Urology|December 18, 2018
Androgen Deprivation Therapy and Overall Survival for Gleason 8 Versus Gleason 9-10 Prostate CancerDavid D Yang, Brandon A Mahal, Vinayak Muralidhar, et al.
The Spine Journal : Official Journal of the North American Spine Society|September 2, 2015
Early magnetic resonance imaging biomarkers to predict local control after high dose stereotactic body radiotherapy for patients with sarcoma spine metastasesDaniel E Spratt, Julio Arevalo-Perez, Jonathan E Leeman, et al.
Pageof 67